173 related articles for article (PubMed ID: 35364609)
1. Thymosin α-1 Reverses M2 Polarization of Tumor-Associated Macrophages during Efferocytosis.
Wei YT; Wang XR; Yan C; Huang F; Zhang Y; Liu X; Wen ZF; Sun XT; Zhang Y; Chen YQ; Gao R; Pan N; Wang LX
Cancer Res; 2022 May; 82(10):1991-2002. PubMed ID: 35364609
[TBL] [Abstract][Full Text] [Related]
2. Thymosin α-1 in cancer therapy: Immunoregulation and potential applications.
Wei Y; Zhang Y; Li P; Yan C; Wang L
Int Immunopharmacol; 2023 Apr; 117():109744. PubMed ID: 36812669
[TBL] [Abstract][Full Text] [Related]
3. Targeting MerTK decreases efferocytosis and increases anti-tumor immune infiltrate in prostate cancer.
Myers Chen KV; de Groot AE; Mendez SA; Mallin MM; Amend SR; Pienta KJ
Med Oncol; 2023 Aug; 40(10):284. PubMed ID: 37644281
[TBL] [Abstract][Full Text] [Related]
4. Polarization of prostate cancer-associated macrophages is induced by milk fat globule-EGF factor 8 (MFG-E8)-mediated efferocytosis.
Soki FN; Koh AJ; Jones JD; Kim YW; Dai J; Keller ET; Pienta KJ; Atabai K; Roca H; McCauley LK
J Biol Chem; 2014 Aug; 289(35):24560-72. PubMed ID: 25006249
[TBL] [Abstract][Full Text] [Related]
5. MerTK-mediated efferocytosis promotes immune tolerance and tumor progression in osteosarcoma through enhancing M2 polarization and PD-L1 expression.
Lin J; Xu A; Jin J; Zhang M; Lou J; Qian C; Zhu J; Wang Y; Yang Z; Li X; Yu W; Liu B; Tao H
Oncoimmunology; 2022; 11(1):2024941. PubMed ID: 35036076
[TBL] [Abstract][Full Text] [Related]
6. ICAM-1 suppresses tumor metastasis by inhibiting macrophage M2 polarization through blockade of efferocytosis.
Yang M; Liu J; Piao C; Shao J; Du J
Cell Death Dis; 2015 Jun; 6(6):e1780. PubMed ID: 26068788
[TBL] [Abstract][Full Text] [Related]
7. Macrophage-Derived Neuropilin-2 Exhibits Novel Tumor-Promoting Functions.
Roy S; Bag AK; Dutta S; Polavaram NS; Islam R; Schellenburg S; Banwait J; Guda C; Ran S; Hollingsworth MA; Singh RK; Talmadge JE; Muders MH; Batra SK; Datta K
Cancer Res; 2018 Oct; 78(19):5600-5617. PubMed ID: 30111533
[TBL] [Abstract][Full Text] [Related]
8. M2 polarization of tumor-associated macrophages is dependent on integrin β3 via peroxisome proliferator-activated receptor-γ up-regulation in breast cancer.
Shu Y; Qin M; Song Y; Tang Q; Huang Y; Shen P; Lu Y
Immunology; 2020 Aug; 160(4):345-356. PubMed ID: 32311768
[TBL] [Abstract][Full Text] [Related]
9. The complex roles of efferocytosis in cancer development, metastasis, and treatment.
Tajbakhsh A; Gheibi Hayat SM; Movahedpour A; Savardashtaki A; Loveless R; Barreto GE; Teng Y; Sahebkar A
Biomed Pharmacother; 2021 Aug; 140():111776. PubMed ID: 34062411
[TBL] [Abstract][Full Text] [Related]
10. MFG-E8 promotes tendon-bone healing by regualting macrophage efferocytosis and M2 polarization after anterior cruciate ligament reconstruction.
Geng R; Lin Y; Ji M; Chang Q; Li Z; Xu L; Zhang W; Lu J
J Orthop Translat; 2022 May; 34():11-21. PubMed ID: 35615640
[TBL] [Abstract][Full Text] [Related]
11. Thymosin alpha 1 - Reimagine its broader applications in the immuno-oncology era.
Mao L
Int Immunopharmacol; 2023 Apr; 117():109952. PubMed ID: 36871535
[TBL] [Abstract][Full Text] [Related]
12. Urokinase-type plasminogen activator receptor is required for impairing toll-like receptor 7 signaling on macrophage efferocytosis in lupus.
Li J; Pan Y; Li D; Xia X; Jiang Q; Dou H; Hou Y
Mol Immunol; 2020 Nov; 127():38-45. PubMed ID: 32911323
[TBL] [Abstract][Full Text] [Related]
13. Wnt5a-induced M2 polarization of tumor-associated macrophages via IL-10 promotes colorectal cancer progression.
Liu Q; Yang C; Wang S; Shi D; Wei C; Song J; Lin X; Dou R; Bai J; Xiang Z; Huang S; Liu K; Xiong B
Cell Commun Signal; 2020 Mar; 18(1):51. PubMed ID: 32228612
[TBL] [Abstract][Full Text] [Related]
14. Docosahexaenoic acid induces M2 macrophage polarization through peroxisome proliferator-activated receptor γ activation.
Chang HY; Lee HN; Kim W; Surh YJ
Life Sci; 2015 Jan; 120():39-47. PubMed ID: 25445227
[TBL] [Abstract][Full Text] [Related]
15. RNA-based modulation of macrophage-mediated efferocytosis potentiates antitumor immunity in colorectal cancer.
Zhou X; Li D; Xia S; Ma X; Li R; Mu Y; Liu Z; Zhang L; Zhou Q; Zhuo W; Ding K; Lin A; Liu W; Liu X; Zhou T
J Control Release; 2024 Feb; 366():128-141. PubMed ID: 38104775
[TBL] [Abstract][Full Text] [Related]
16. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
[TBL] [Abstract][Full Text] [Related]
17. The role of NFATc1/c-myc/PKM2/IL-10 axis in activating cervical cancer tumor-associated M2 macrophage polarization to promote cervical cancer progression.
Tan J; Yang L; Zhao H; Ai Y; Ren L; Zhang F; Dong W; Shi R; Sun D; Feng Y
Exp Cell Res; 2022 Apr; 413(2):113052. PubMed ID: 35122827
[TBL] [Abstract][Full Text] [Related]
18. CD276-dependent efferocytosis by tumor-associated macrophages promotes immune evasion in bladder cancer.
Cheng M; Chen S; Li K; Wang G; Xiong G; Ling R; Zhang C; Zhang Z; Han H; Chen Z; Wang X; Liang Y; Tian G; Zhou R; Zhu Y; Ma J; Liu J; Lin S; Xu H; Chen D; Li Y; Peng L
Nat Commun; 2024 Apr; 15(1):2818. PubMed ID: 38561369
[TBL] [Abstract][Full Text] [Related]
19. Radio-chemotherapy of glioblastoma cells promotes phagocytosis by macrophages in vitro.
Lecoultre M; Chliate S; Espinoza FI; Tankov S; Dutoit V; Walker PR
Radiother Oncol; 2024 Jan; 190():110049. PubMed ID: 38072365
[TBL] [Abstract][Full Text] [Related]
20. Treatment-Induced Tumor Cell Apoptosis and Secondary Necrosis Drive Tumor Progression in the Residual Tumor Microenvironment through MerTK and IDO1.
Werfel TA; Elion DL; Rahman B; Hicks DJ; Sanchez V; Gonzales-Ericsson PI; Nixon MJ; James JL; Balko JM; Scherle PA; Koblish HK; Cook RS
Cancer Res; 2019 Jan; 79(1):171-182. PubMed ID: 30413412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
